Advanced Biomed Inc. (ADVB) Financial Statements
Advanced Biomed Inc. (ADVB) files with the U.S. Securities and Exchange Commission under CIK 0001941029. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2026
- Revenue
- $127.64 thousand
- Net Income
- $6.68 million
- Total Assets
- $13.75 million
- Net Cash from Operations
- -$1.95 million
Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Oct 13, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for ADVB in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History